$PCRX
Pacira Biosciences Inc Stock $pcrx

$pcrx Overview Financials Valuation SEC Filings Company Website

2016 Q2 Form 10-Q Financial Statement

#000139681416000023 Filed on August 04, 2016

Income Statement

Concept	2016 Q2	2015 Q2
Revenue	$69.64M	$59.15M
YoY Change	17.74%	25.41%
Cost Of Revenue	$23.05M	$18.93M
YoY Change	21.79%	-5.14%
Gross Profit	$46.59M	$40.22M
YoY Change	15.83%	47.8%
Gross Profit Margin	66.9%	68.0%
Selling, General & Admin	$43.67M	$34.75M
YoY Change	25.66%	39.92%
% of Gross Profit	93.74%	86.41%
Research & Development	$9.362M	$3.649M
YoY Change	156.56%	-30.04%
% of Gross Profit	20.1%	9.07%
Depreciation & Amortization	$3.200M	$2.700M
YoY Change	18.52%	17.39%
% of Gross Profit	6.87%	6.71%
Operating Expenses	$76.08M	$57.33M
YoY Change	32.71%	14.64%
Operating Profit	-$6.444M	$1.818M
YoY Change	-454.46%	-163.97%
Interest Expense	$1.733M	$1.940M
YoY Change	-10.67%	-6.69%
% of Operating Profit		106.71%
Other Income/Expense, Net	-$1.456M	-$1.771M
YoY Change	-17.79%	-19.32%
Pretax Income	-$7.900M	$47.00K
YoY Change	-16908.51%	-100.93%
Income Tax	$58.00K	$39.00K
% Of Pretax Income		82.98%
Net Earnings	-$7.958M	$8.000K
YoY Change	-99575.0%	-100.16%
Net Earnings / Revenue	-11.43%	0.01%
Basic Earnings Per Share	-$0.21
Diluted Earnings Per Share	-$215.1K	$0.00
COMMON SHARES
Basic Shares Outstanding	37.18M shares	36.48M shares
Diluted Shares Outstanding	37.18M shares	41.45M shares

Balance Sheet

Concept	2016 Q2	2015 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$162.7M	$153.1M
YoY Change	6.27%	-6.59%
Cash & Equivalents	$116.9M	$32.72M
Short-Term Investments	$137.4M	$120.4M
Other Short-Term Assets	$5.800M	$3.400M
YoY Change	70.59%	-35.85%
Inventory	$60.92M	$48.77M
Prepaid Expenses
Receivables	$28.65M	$24.28M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$258.0M	$229.6M
YoY Change	12.35%	9.92%
LONG-TERM ASSETS
Property, Plant & Equipment	$99.28M	$77.81M
YoY Change	27.6%	45.4%
Goodwill	$42.75M	$27.12M
YoY Change	57.62%	116.64%
Intangibles
YoY Change
Long-Term Investments	$0.00	$17.90M
YoY Change	-100.0%	32.59%
Other Assets	$677.0K	$2.252M
YoY Change	-69.94%	-27.43%
Total Long-Term Assets	$142.7M	$125.4M
YoY Change	13.83%	50.73%
TOTAL ASSETS
Total Short-Term Assets	$258.0M	$229.6M
Total Long-Term Assets	$142.7M	$125.4M
Total Assets	$400.7M	$355.0M
YoY Change	12.88%	21.54%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$4.614M	$13.30M
YoY Change	-65.31%	322.86%
Accrued Expenses	$38.33M	$26.79M
YoY Change	43.08%	16.3%
Deferred Revenue
YoY Change
Short-Term Debt	$106.4M	$103.9M
YoY Change	2.41%	2.87%
Long-Term Debt Due		$0.00
YoY Change		-100.0%
Total Short-Term Liabilities	$150.4M	$145.5M
YoY Change	3.41%	12.33%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$14.16M	$5.447M
YoY Change	160.01%	24.25%
Total Long-Term Liabilities	$14.16M	$5.447M
YoY Change	160.01%	24.25%
TOTAL LIABILITIES
Total Short-Term Liabilities	$150.4M	$145.5M
Total Long-Term Liabilities	$14.16M	$5.447M
Total Liabilities	$172.3M	$159.7M
YoY Change	7.91%	10.83%
SHAREHOLDERS EQUITY
Retained Earnings	-$320.1M	-$308.9M
YoY Change	3.63%	-1.3%
Common Stock	$37.00K	$37.00K
YoY Change	0.0%	2.78%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares	0.000 shares	0.000 shares
Shareholders Equity	$228.4M	$195.3M
YoY Change
Total Liabilities & Shareholders Equity	$400.7M	$355.0M
YoY Change	12.88%	21.54%

Cashflow Statement

Concept	2016 Q2	2015 Q2
OPERATING ACTIVITIES
Net Income	-$7.958M	$8.000K
YoY Change	-99575.0%	-100.16%
Depreciation, Depletion And Amortization	$3.200M	$2.700M
YoY Change	18.52%	17.39%
Cash From Operating Activities	$7.540M	$10.01M
YoY Change	-24.68%	21.78%
INVESTING ACTIVITIES
Capital Expenditures	-$8.870M	-$14.67M
YoY Change	-39.54%	143.69%
Acquisitions
YoY Change
Other Investing Activities	-$10.78M	-$6.170M
YoY Change	74.72%	-74.87%
Cash From Investing Activities	-$19.64M	-$20.85M
YoY Change	-5.8%	-31.82%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	2.380M	2.650M
YoY Change	-10.19%	-97.63%
NET CHANGE
Cash From Operating Activities	7.540M	10.01M
Cash From Investing Activities	-19.64M	-20.85M
Cash From Financing Activities	2.380M	2.650M
Net Change In Cash	-9.720M	-8.190M
YoY Change	18.68%	-109.16%
FREE CASH FLOW
Cash From Operating Activities	$7.540M	$10.01M
Capital Expenditures	-$8.870M	-$14.67M
Free Cash Flow	$16.41M	$24.68M
YoY Change	-33.51%	73.31%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2016
	dei	Document Period End Date DocumentPeriodEndDate	2016-06-30
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0001396814
CY2016Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	37278231	shares
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Entity Registrant Name EntityRegistrantName	Pacira Pharmaceuticals, Inc.
	pcrx	Amortization Of Other Assets And Unfavorable Lease Obligation AmortizationOfOtherAssetsAndUnfavorableLeaseObligation	241000	USD
	pcrx	Amortization Of Other Assets And Unfavorable Lease Obligation AmortizationOfOtherAssetsAndUnfavorableLeaseObligation	240000	USD
	pcrx	Collaborative Agreement Fee Payment Period CollaborativeAgreementFeePaymentPeriod	P2Y
CY2013Q4	pcrx	Collaborative Arrangement Agreement Term CollaborativeArrangementAgreementTerm	P5Y
CY2015Q2	pcrx	Collaborative Licensing And Development Revenue CollaborativeLicensingAndDevelopmentRevenue	356000	USD
	pcrx	Collaborative Licensing And Development Revenue CollaborativeLicensingAndDevelopmentRevenue	713000	USD
CY2016Q2	pcrx	Collaborative Licensing And Development Revenue CollaborativeLicensingAndDevelopmentRevenue	1356000	USD
	pcrx	Collaborative Licensing And Development Revenue CollaborativeLicensingAndDevelopmentRevenue	1713000	USD
CY2015Q2	pcrx	Compensationexpensefromemployeestockpurchaseplan Compensationexpensefromemployeestockpurchaseplan	242000	USD
	pcrx	Compensationexpensefromemployeestockpurchaseplan Compensationexpensefromemployeestockpurchaseplan	453000	USD
CY2016Q2	pcrx	Compensationexpensefromemployeestockpurchaseplan Compensationexpensefromemployeestockpurchaseplan	299000	USD
	pcrx	Compensationexpensefromemployeestockpurchaseplan Compensationexpensefromemployeestockpurchaseplan	574000	USD
CY2015Q2	pcrx	Compensationexpensefromstockoptionsemployees Compensationexpensefromstockoptionsemployees	6739000	USD
	pcrx	Compensationexpensefromstockoptionsemployees Compensationexpensefromstockoptionsemployees	13049000	USD
CY2016Q2	pcrx	Compensationexpensefromstockoptionsemployees Compensationexpensefromstockoptionsemployees	5789000	USD
	pcrx	Compensationexpensefromstockoptionsnonemployeeawards Compensationexpensefromstockoptionsnonemployeeawards	942000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	1321000	USD
	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	700000	USD
	pcrx	Compensationexpensefromstockoptionsemployees Compensationexpensefromstockoptionsemployees	12633000	USD
CY2015Q2	pcrx	Compensationexpensefromstockoptionsnonemployeeawards Compensationexpensefromstockoptionsnonemployeeawards	-54000	USD
CY2016Q2	pcrx	Compensationexpensefromstockoptionsnonemployeeawards Compensationexpensefromstockoptionsnonemployeeawards	437000	USD
	pcrx	Compensationexpensefromstockoptionsnonemployeeawards Compensationexpensefromstockoptionsnonemployeeawards	723000	USD
CY2012Q2	pcrx	Contingent Payment Obligation Established For Sale Of Product In Connection With Acquisition ContingentPaymentObligationEstablishedForSaleOfProductInConnectionWithAcquisition	2000000	USD
CY2016Q2	pcrx	Contract Termination Fee ContractTerminationFee	7200000	USD
CY2016Q2	pcrx	Contract Termination Fee Current Portion ContractTerminationFeeCurrentPortion	3600000	USD
CY2016Q2	pcrx	Contract Termination Fee Long Term Portion ContractTerminationFeeLongTermPortion	3600000	USD
CY2015Q2	pcrx	Conversion Request Convertible Senior Notes ConversionRequestConvertibleSeniorNotes	1500000	USD
	pcrx	Conversionofprincipalandequitycomponentofconvertibleseniornotes Conversionofprincipalandequitycomponentofconvertibleseniornotes	1466000	USD
	pcrx	Conversionofprincipalandequitycomponentofconvertibleseniornotes Conversionofprincipalandequitycomponentofconvertibleseniornotes	4000	USD
CY2016Q2	pcrx	Debt Instrument Convertible Conversion Premium Shares DebtInstrumentConvertibleConversionPremiumShares	1300000	shares
CY2016Q2	pcrx	Debt Instrument Convertible Conversion Value DebtInstrumentConvertibleConversionValue	42600000	USD
	pcrx	Fair Market Valueof Common Stock Issuedfor Convertible Senior Notes Premium FairMarketValueofCommonStockIssuedforConvertibleSeniorNotesPremium	3930000	USD
	pcrx	Fair Market Valueof Common Stock Issuedfor Convertible Senior Notes Premium FairMarketValueofCommonStockIssuedforConvertibleSeniorNotesPremium	0	USD
CY2015Q4	pcrx	Foreign Property Plantand Equipment Net ForeignPropertyPlantandEquipmentNet	25900000	USD
CY2016Q2	pcrx	Foreign Property Plantand Equipment Net ForeignPropertyPlantandEquipmentNet	29900000	USD
	pcrx	Goodwill Recordedfor Earn Out Payments GoodwillRecordedforEarnOutPayments	3871000	USD
	pcrx	Goodwill Recordedon Milestone Payments GoodwillRecordedonMilestonePayments	8000000	USD
CY2015Q2	pcrx	Income Lossfrom Continuing Operationsbefore Income Taxes Total IncomeLossfromContinuingOperationsbeforeIncomeTaxesTotal	47000	USD
	pcrx	Income Lossfrom Continuing Operationsbefore Income Taxes Total IncomeLossfromContinuingOperationsbeforeIncomeTaxesTotal	1359000	USD
CY2016Q2	pcrx	Income Lossfrom Continuing Operationsbefore Income Taxes Total IncomeLossfromContinuingOperationsbeforeIncomeTaxesTotal	-7900000	USD
	pcrx	Income Lossfrom Continuing Operationsbefore Income Taxes Total IncomeLossfromContinuingOperationsbeforeIncomeTaxesTotal	-11722000	USD
	pcrx	Income Tax Provision IncomeTaxProvision	100000	USD
CY2016Q2	pcrx	Income Tax Provision IncomeTaxProvision	100000	USD
	pcrx	Increase Decrease In Royalty Interest Obligation IncreaseDecreaseInRoyaltyInterestObligation	276000	USD
	pcrx	Increase Decrease In Royalty Interest Obligation IncreaseDecreaseInRoyaltyInterestObligation	0	USD
	pcrx	Milestone Payments Incurred But Not Yet Paid MilestonePaymentsIncurredButNotYetPaid	0	USD
	pcrx	Milestone Payments Incurred But Not Yet Paid MilestonePaymentsIncurredButNotYetPaid	-8000000	USD
CY2015	pcrx	Number Of Major Customers NumberOfMajorCustomers	3	customer
	pcrx	Number Of Major Customers NumberOfMajorCustomers	3	customer
CY2012Q2	pcrx	Payment Obligation Arising Due To First Commercial Sale Of Product In Connection With Acquisition PaymentObligationArisingDueToFirstCommercialSaleOfProductInConnectionWithAcquisition	10000000	USD
	pcrx	Payment Of Contingent Consideration PaymentOfContingentConsideration	3362000	USD
	pcrx	Payment Of Contingent Consideration PaymentOfContingentConsideration	3871000	USD
	pcrx	Proceedsfrom Shares Issued Under Employee Stock Purchase Plans ProceedsfromSharesIssuedUnderEmployeeStockPurchasePlans	1195000	USD
	pcrx	Proceedsfrom Shares Issued Under Employee Stock Purchase Plans ProceedsfromSharesIssuedUnderEmployeeStockPurchasePlans	995000	USD
CY2015Q2	pcrx	Settlement Period Convertible Debt Conversion Request SettlementPeriodConvertibleDebtConversionRequest	P40D
CY2016Q2	pcrx	Total Goodwill Recordedfor Earn Out Payments TotalGoodwillRecordedforEarnOutPayments	18800000	USD
CY2015Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	8739000	USD
CY2016Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	4614000	USD
CY2015Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	25855000	USD
CY2016Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	28651000	USD
CY2015Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	35375000	USD
CY2016Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	38330000	USD
CY2015Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	24917000	USD
CY2016Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	31210000	USD
CY2015Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-52000	USD
CY2016Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	138000	USD
CY2015Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	526696000	USD
CY2016Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	548277000	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized	4000000	shares
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	16155000	USD
CY2015Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	7296000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	14813000	USD
CY2016Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	7665000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	16155000	USD
CY2015Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	USD
CY2016Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	USD
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	2058000	USD
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	2044000	USD
CY2015Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	100000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	200000	USD
CY2016Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	0	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	100000	USD
CY2015Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1738000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1530000	shares
CY2016Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	6836000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	7070000	shares
CY2015Q4	us-gaap	Assets Assets	387735000	USD
CY2016Q2	us-gaap	Assets Assets	400699000	USD
CY2015Q4	us-gaap	Assets Current AssetsCurrent	252582000	USD
CY2016Q2	us-gaap	Assets Current AssetsCurrent	257989000	USD
CY2015Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	115495000	USD
CY2016Q2	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	137220000	USD
CY2015Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	33000	USD
CY2016Q2	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	157000	USD
CY2015Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	85000	USD
CY2016Q2	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	19000	USD
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	4150000	USD
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	662000	USD
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	37520000	USD
CY2015Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	32722000	USD
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	56984000	USD
CY2016Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	25309000	USD
CY2015Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2016Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2015Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2016Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2015Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2016Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2015Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	36848319	shares
CY2016Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	37273407	shares
CY2015Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	36848319	shares
CY2016Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	37273407	shares
CY2015Q4	us-gaap	Common Stock Value CommonStockValue	37000	USD
CY2016Q2	us-gaap	Common Stock Value CommonStockValue	37000	USD
CY2015Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	9000	USD
CY2016Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-7869000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-11622000	USD
CY2015Q4	us-gaap	Convertible Debt ConvertibleDebt	118533000	USD
CY2016Q2	us-gaap	Convertible Debt ConvertibleDebt	118531000	USD
CY2015Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	104040000	USD
CY2016Q2	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	106388000	USD
CY2015Q2	us-gaap	Cost Of Revenue CostOfRevenue	18929000	USD
	us-gaap	Cost Of Revenue CostOfRevenue	36509000	USD
CY2016Q2	us-gaap	Cost Of Revenue CostOfRevenue	23053000	USD
	us-gaap	Cost Of Revenue CostOfRevenue	43331000	USD
CY2016Q2	us-gaap	Debt Conversion Converted Instrument Shares Issued1 DebtConversionConvertedInstrumentSharesIssued1	1300000	shares
CY2016Q2	us-gaap	Debt Instrument Convertible Threshold Consecutive Trading Days DebtInstrumentConvertibleThresholdConsecutiveTradingDays	P30D
CY2016Q2	us-gaap	Debt Instrument Convertible Threshold Percentage Of Stock Price Trigger DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger	1.3
CY2016Q2	us-gaap	Debt Instrument Convertible Threshold Trading Days DebtInstrumentConvertibleThresholdTradingDays	20	D
CY2015Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	12605000	USD
CY2016Q2	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	10561000	USD
CY2015Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	1888000	USD
CY2016Q2	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	1582000	USD
CY2015Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	1426000	USD
CY2016Q2	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	1048000	USD
CY2015Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	8082000	USD
CY2016Q2	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	7747000	USD
CY2015Q2	us-gaap	Depreciation Depreciation	2700000	USD
	us-gaap	Depreciation Depreciation	5400000	USD
CY2016Q2	us-gaap	Depreciation Depreciation	3200000	USD
	us-gaap	Depreciation Depreciation	6300000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	5526000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	6381000	USD
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.03
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.32
CY2015Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	0.00
CY2016Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.21
CY2015Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	14919000	USD
CY2016Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	15000000	USD
CY2015Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	15000000	USD
CY2016Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	15000000	USD
CY2015Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	81000	USD
CY2016Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	0	USD
CY2015Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-100000	USD
CY2015Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-51000	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-51000	USD
CY2016Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	40.92
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	22.06
CY2015Q4	us-gaap	Goodwill Goodwill	30880000	USD
CY2016Q2	us-gaap	Goodwill Goodwill	42751000	USD
CY2012Q2	us-gaap	Goodwill Goodwill	8000000	USD
CY2015Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	352000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	2238000	USD
CY2016Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-7526000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-11025000	USD
CY2015Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	47000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1359000	USD
CY2016Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-7900000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-11722000	USD
CY2015Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-305000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-879000	USD
CY2016Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-374000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-697000	USD
CY2015Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	39000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	91000	USD
CY2016Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	58000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	90000	USD
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	159000	USD
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	241000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	2182000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-8658000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1915000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	2796000	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-713000	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-713000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	19506000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-729000	USD
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	38000	USD
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	2758000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1032000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-92000	USD
	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	-1509000	USD
	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	0	USD
CY2015Q2	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	6000	shares
	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	6000	shares
CY2016Q2	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0	shares
	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0	shares
CY2015Q2	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	3277000	shares
	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	3465000	shares
CY2016Q2	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	0	shares
	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	0	shares
CY2015Q2	us-gaap	Incremental Common Shares Attributable To Equity Unit Purchase Agreements IncrementalCommonSharesAttributableToEquityUnitPurchaseAgreements	1000	shares
	us-gaap	Incremental Common Shares Attributable To Equity Unit Purchase Agreements IncrementalCommonSharesAttributableToEquityUnitPurchaseAgreements	1000	shares
CY2016Q2	us-gaap	Incremental Common Shares Attributable To Equity Unit Purchase Agreements IncrementalCommonSharesAttributableToEquityUnitPurchaseAgreements	0	shares
	us-gaap	Incremental Common Shares Attributable To Equity Unit Purchase Agreements IncrementalCommonSharesAttributableToEquityUnitPurchaseAgreements	0	shares
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Purchase Price Of Common Stock Percent SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent	0.85
	us-gaap	Stock Issued During Period Shares Employee Stock Purchase Plans StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans	35000	shares
CY2016Q2	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	400000	USD
CY2015Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1680000	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1782000	shares
CY2016Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2015Q2	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	200000	USD
	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	400000	USD
CY2015Q2	us-gaap	Interest Expense InterestExpense	1940000	USD
	us-gaap	Interest Expense InterestExpense	3935000	USD
CY2016Q2	us-gaap	Interest Expense InterestExpense	1733000	USD
	us-gaap	Interest Expense InterestExpense	3601000	USD
	us-gaap	Interest Paid InterestPaid	2297000	USD
	us-gaap	Interest Paid InterestPaid	1926000	USD
CY2015Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	32781000	USD
CY2016Q2	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	44515000	USD
CY2015Q4	us-gaap	Inventory Net InventoryNet	61645000	USD
CY2016Q2	us-gaap	Inventory Net InventoryNet	60916000	USD
CY2015Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	16712000	USD
CY2016Q2	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	14436000	USD
CY2015Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	12152000	USD
CY2016Q2	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	1965000	USD
CY2015Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	177000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	332000	USD
CY2016Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	324000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	576000	USD
CY2015Q4	us-gaap	Liabilities Liabilities	169343000	USD
CY2016Q2	us-gaap	Liabilities Liabilities	172348000	USD
CY2015Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	387735000	USD
CY2016Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	400699000	USD
CY2015Q4	us-gaap	Liabilities Current LiabilitiesCurrent	149788000	USD
CY2016Q2	us-gaap	Liabilities Current LiabilitiesCurrent	150438000	USD
CY2015Q4	us-gaap	Long Term Debt LongTermDebt	104040000	USD
CY2016Q2	us-gaap	Long Term Debt LongTermDebt	106388000	USD
CY2015Q4	us-gaap	Long Term Investments LongTermInvestments	13462000	USD
CY2016Q2	us-gaap	Long Term Investments LongTermInvestments	0	USD
	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	-4798000	USD
	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	-31675000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	6704000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	5422000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-17810000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-41517000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	6308000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	4420000	USD
CY2015Q2	us-gaap	Net Income Loss NetIncomeLoss	8000	USD
	us-gaap	Net Income Loss NetIncomeLoss	1268000	USD
	us-gaap	Stock Issued During Period Shares Employee Stock Purchase Plans StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans	34705	shares
	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	995000	USD
CY2016Q2	us-gaap	Net Income Loss NetIncomeLoss	-7958000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-11812000	USD
CY2015Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1771000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-3799000	USD
CY2016Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1456000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-3024000	USD
CY2015Q2	us-gaap	Operating Expenses OperatingExpenses	57330000	USD
	us-gaap	Operating Expenses OperatingExpenses	112305000	USD
CY2016Q2	us-gaap	Operating Expenses OperatingExpenses	76084000	USD
	us-gaap	Operating Expenses OperatingExpenses	143812000	USD
CY2015Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	1818000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	5158000	USD
CY2016Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-6444000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-8698000	USD
CY2016Q2	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	43231000	USD
CY2016Q2	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	6420000	USD
CY2016Q2	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	8303000	USD
CY2016Q2	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	8081000	USD
CY2016Q2	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	7878000	USD
CY2016Q2	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	8731000	USD
CY2016Q2	us-gaap	Operating Leases Future Minimum Payments Remainder Of Fiscal Year OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear	3818000	USD
CY2015Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	406000	USD
CY2016Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	677000	USD
CY2015Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	1000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	53000	USD
CY2016Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	89000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	190000	USD
CY2015Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	1000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	53000	USD
CY2016Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	89000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	190000	USD
CY2015Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	11473000	USD
CY2016Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	14163000	USD
CY2015Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	43000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-74000	USD
CY2016Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-47000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	19706000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	15921000	USD
	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	92921000	USD
	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	121790000	USD
CY2015Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2016Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2015Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2016Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2015Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	0	USD
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	4431000	USD
CY2016Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2015Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2016Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2015Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2016Q2	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2015Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	6117000	USD
CY2016Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	5755000	USD
	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	98179000	USD
	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	100065000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	6975000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	4431000	USD
CY2015Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	115241000	USD
CY2016Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	130492000	USD
CY2015Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	90324000	USD
CY2016Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	99282000	USD
CY2015Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3649000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	9616000	USD
CY2016Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	9362000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	18855000	USD
CY2015Q2	us-gaap	Restricted Stock Expense RestrictedStockExpense	369000	USD
	us-gaap	Restricted Stock Expense RestrictedStockExpense	369000	USD
CY2016Q2	us-gaap	Restricted Stock Expense RestrictedStockExpense	1140000	USD
	us-gaap	Restricted Stock Expense RestrictedStockExpense	2225000	USD
CY2015Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-308289000	USD
CY2016Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-320101000	USD
CY2015Q2	us-gaap	Revenues Revenues	59148000	USD
	us-gaap	Revenues Revenues	117463000	USD
CY2016Q2	us-gaap	Revenues Revenues	69640000	USD
	us-gaap	Revenues Revenues	135114000	USD
CY2015Q2	us-gaap	Royalty Expense RoyaltyExpense	0	USD
	us-gaap	Royalty Expense RoyaltyExpense	71000	USD
CY2016Q2	us-gaap	Royalty Expense RoyaltyExpense	0	USD
	us-gaap	Royalty Expense RoyaltyExpense	0	USD
CY2015Q2	us-gaap	Royalty Revenue RoyaltyRevenue	730000	USD
	us-gaap	Royalty Revenue RoyaltyRevenue	1604000	USD
CY2016Q2	us-gaap	Royalty Revenue RoyaltyRevenue	597000	USD
	us-gaap	Royalty Revenue RoyaltyRevenue	1212000	USD
CY2015Q2	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	58062000	USD
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	115146000	USD
CY2016Q2	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	67687000	USD
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	132189000	USD
CY2015Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	34752000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	66180000	USD
CY2016Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	43669000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	81626000	USD
CY2015Q2	us-gaap	Share Based Compensation ShareBasedCompensation	7296000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	14813000	USD
CY2016Q2	us-gaap	Share Based Compensation ShareBasedCompensation	7665000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	16155000	USD
CY2016Q2	us-gaap	Share Price SharePrice	33.73
CY2015Q4	us-gaap	Short Term Investments ShortTermInvestments	101981000	USD
CY2016Q2	us-gaap	Short Term Investments ShortTermInvestments	137358000	USD
CY2015Q4	us-gaap	Stockholders Equity StockholdersEquity	218392000	USD
CY2016Q2	us-gaap	Stockholders Equity StockholdersEquity	228351000	USD
CY2015Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	208000	USD
CY2016Q2	us-gaap	Taxes Payable Current TaxesPayableCurrent	58000	USD
CY2015Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	0	shares
CY2016Q2	us-gaap	Treasury Stock Shares TreasuryStockShares	0	shares
CY2015Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	41445000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	41612000	shares
CY2016Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	37181000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	37101000	shares
CY2015Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	36481000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	36358000	shares
CY2016Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	37181000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	37101000	shares

Files In Submission

Name	View Source	Status
0001396814-16-000023-index-headers.html	Edgar Link	pending
0001396814-16-000023-index.html	Edgar Link	pending
0001396814-16-000023.txt	Edgar Link	pending
0001396814-16-000023-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
pcrx-20160630.xml	Edgar Link	completed
pcrx-20160630.xsd	Edgar Link	pending
pcrx-20160630_cal.xml	Edgar Link	unprocessable
pcrx-20160630_def.xml	Edgar Link	unprocessable
pcrx-20160630_lab.xml	Edgar Link	unprocessable
pcrx-20160630_pre.xml	Edgar Link	unprocessable
pcrx-63016xex101.htm	Edgar Link	pending
pcrx-63016xex311.htm	Edgar Link	pending
pcrx-63016xex312.htm	Edgar Link	pending
pcrx-63016xex321.htm	Edgar Link	pending
pcrx-63016xex322.htm	Edgar Link	pending
pcrx-6302016x10xq.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PCRX
Pacira Biosciences Inc Stock $pcrx

2016 Q2 Form 10-Q Financial Statement

#000139681416000023 Filed on August 04, 2016

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PCRX Pacira Biosciences Inc Stock $pcrx

2016 Q2 Form 10-Q Financial Statement

#000139681416000023 Filed on August 04, 2016

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PCRX
Pacira Biosciences Inc Stock $pcrx